Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gordon

Showing results (181-190 of 201) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid TumorsAni S Balmanoukian, Jeffrey R Infante, Raid Aljumaily, et al.
Brazilian Journal of Physical Therapy|August 5, 2019
Alterations in knee sensorimotor brain functional connectivity contributes to ACL injury in male high-school football players: a prospective neuroimaging analysisJed A Diekfuss, Dustin R Grooms, Katharine S Nissen, et al.
Expert Review of Respiratory Medicine|July 8, 2024
The use of venous blood gas in assessing arterial acid-base and oxygenation status - an analysis of aggregated data from multiple studies evaluating the venous to arterial conversion (v-TAC) methodLisha Shastri, Lars Pilegaard Thomsen, Marianne Toftegaard, et al.
JAMA Oncology|January 25, 2019
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor TrialMary L Disis, Matthew H Taylor, Karen Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2021
Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I StudyDaniel P Petrylak, Yohann Loriot, David R Shaffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancerHelen K Chew, James H Doroshow, Paul Frankel, et al.
Oncoimmunology|July 6, 2026
Preclinical proof of concept for a personalized SNAP™-TIL (Specific Neo-Antigen Peptides-TIL) therapy platformTithi Ghosh Halder, Erin Kelley, Jorge Soria-Bustos, et al.
Annals of Emergency Medicine|February 16, 2025
PEAChY-O: Pharmacological Emergency Management of Agitation in Children and Young People: A Randomized Controlled Trial of Oral MedicationElyssia M Bourke, Amit Kochar, Deborah Shellshear, et al.
Emergency Medicine Australasia : EMA|May 28, 2026
Recreational Drug Use Amongst Children and Adolescents Presenting to Australian Emergency Departments With Acute Behavioural Disturbance: A Secondary Analysis of a Randomised Controlled TrialElyssia M Bourke, Kate Klein, Chris J Selman, et al.
The Oncologist|January 16, 2021
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of TherapySuzanne George, Robin L Jones, Sebastian Bauer, et al.
Pageof 21

Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid TumorsAni S Balmanoukian, Jeffrey R Infante, Raid Aljumaily, et al.
Brazilian Journal of Physical Therapy|August 5, 2019
Alterations in knee sensorimotor brain functional connectivity contributes to ACL injury in male high-school football players: a prospective neuroimaging analysisJed A Diekfuss, Dustin R Grooms, Katharine S Nissen, et al.
Expert Review of Respiratory Medicine|July 8, 2024
The use of venous blood gas in assessing arterial acid-base and oxygenation status - an analysis of aggregated data from multiple studies evaluating the venous to arterial conversion (v-TAC) methodLisha Shastri, Lars Pilegaard Thomsen, Marianne Toftegaard, et al.
JAMA Oncology|January 25, 2019
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor TrialMary L Disis, Matthew H Taylor, Karen Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2021
Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I StudyDaniel P Petrylak, Yohann Loriot, David R Shaffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancerHelen K Chew, James H Doroshow, Paul Frankel, et al.
Oncoimmunology|July 6, 2026
Preclinical proof of concept for a personalized SNAP™-TIL (Specific Neo-Antigen Peptides-TIL) therapy platformTithi Ghosh Halder, Erin Kelley, Jorge Soria-Bustos, et al.
Annals of Emergency Medicine|February 16, 2025
PEAChY-O: Pharmacological Emergency Management of Agitation in Children and Young People: A Randomized Controlled Trial of Oral MedicationElyssia M Bourke, Amit Kochar, Deborah Shellshear, et al.
Emergency Medicine Australasia : EMA|May 28, 2026
Recreational Drug Use Amongst Children and Adolescents Presenting to Australian Emergency Departments With Acute Behavioural Disturbance: A Secondary Analysis of a Randomised Controlled TrialElyssia M Bourke, Kate Klein, Chris J Selman, et al.
The Oncologist|January 16, 2021
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of TherapySuzanne George, Robin L Jones, Sebastian Bauer, et al.
Pageof 21